Triclofos sodium (Triclos) for insomnia.
D000284:Administration, Oral; D001463:Barbiturates / Q000627:therapeutic use; D001702:Biopharmaceutics; D002214:Capsules; D002697:Chloral Hydrate / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D004347:Drug Interactions; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use*; D010756:Phosphoric Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use*; D010919:Placebos; D011247:Pregnancy; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects; D012964:Sodium; D013405:Suicide
D001463:Barbiturates; D002214:Capsules; D006993:Hypnotics and Sedatives; D010756:Phosphoric Acids; D010919:Placebos; D002697:Chloral Hydrate; D012964:Sodium